Scarica l'app Stockscreener
3.916
2.49%
-0.104
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$4.02
Aprire:
$4.02
Volume 24 ore:
2.49M
Relative Volume:
0.58
Capitalizzazione di mercato:
$386.44M
Reddito:
$775.09M
Utile/perdita netta:
$-58.68M
Rapporto P/E:
-29.53
EPS:
-0.1326
Flusso di cassa netto:
$64.06M
1 W Prestazione:
-15.52%
1M Prestazione:
-7.33%
6M Prestazione:
-11.91%
1 anno Prestazione:
-43.35%
Intervallo 1D:
$3.89
$4.07
Intervallo di 1 settimana:
$3.89
$4.72
Portata 52W:
$3.305
$6.97
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Confronta GDRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
3.92 | 1.44B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
290.98 | 47.15B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
91.18 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.14 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.36 | 8.10B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.45 | 6.99B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Iniziato | Citigroup | Buy |
| 2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-12 | Iniziato | DA Davidson | Neutral |
| 2022-06-10 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-06 | Ripresa | BofA Securities | Buy |
| 2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Reiterato | Barclays | Overweight |
| 2022-03-01 | Reiterato | BofA Securities | Neutral |
| 2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Reiterato | Evercore ISI | Outperform |
| 2022-03-01 | Reiterato | Goldman | Buy |
| 2022-03-01 | Reiterato | JP Morgan | Underweight |
| 2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-03-01 | Reiterato | SVB Leerink | Outperform |
| 2022-01-07 | Iniziato | Goldman | Buy |
| 2021-12-21 | Iniziato | Stephens | Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Guggenheim | Buy |
| 2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Iniziato | Barclays | Equal Weight |
| 2020-10-19 | Iniziato | BofA Securities | Neutral |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-10-19 | Iniziato | Credit Suisse | Outperform |
| 2020-10-19 | Iniziato | Deutsche Bank | Hold |
| 2020-10-19 | Iniziato | Goldman | Neutral |
| 2020-10-19 | Iniziato | JP Morgan | Neutral |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
| 2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Iniziato | SVB Leerink | Outperform |
| 2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
How sentiment analysis helps forecast GoodRx Holdings Inc.July 2025 Sector Moves & Free Community Supported Trade Ideas - newser.com
GoodRx (GDRX) Launches Affordable Hair Loss Treatment Subscripti - GuruFocus
GoodRx launches subscription program for men's hair loss - Seeking Alpha
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment - Stock Titan
How to use a screener to detect GoodRx Holdings Inc. breakoutsPortfolio Update Summary & Community Consensus Trade Alerts - newser.com
Can trapped investors hope for a rebound in GoodRx Holdings Inc.Market Trend Summary & Verified Entry Point Detection - newser.com
Real time social sentiment graph for GoodRx Holdings Inc.Quarterly Profit Report & Technical Entry and Exit Tips - newser.com
How analysts rate GoodRx Holdings Inc. stock todayWeekly Investment Recap & Weekly High Conviction Ideas - newser.com
Institutional scanner results for GoodRx Holdings Inc.Weekly Market Report & Free High Return Stock Watch Alerts - newser.com
What Fibonacci levels say about GoodRx Holdings Inc. rebound2025 Major Catalysts & High Conviction Trade Alerts - newser.com
Will GoodRx Holdings Inc. stock recover after recent dropTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
GoodRx (NASDAQ:GDRX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Up 10.5%Here's Why - MarketBeat
GoodRx Holdings Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & Free High Velocity Capital Growth - earlytimes.in
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know - The Globe and Mail
GoodRx: Novo Deal And TrumpRx Talks Point To EBITDA/FCF Upside (NASDAQ:GDRX) - Seeking Alpha
Price action breakdown for GoodRx Holdings Inc.Quarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
What technical models suggest about GoodRx Holdings Inc.’s comebackPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
GoodRx’s Stock Soars: What’s Behind the Uptick? - timothysykes.com
BofA Securities maintains Underperform rating on GoodRx stock amid TrumpRx uncertainty - Investing.com
GoodRx (GDRX) Faces Uncertain Impact from Potential TrumpRx Coll - GuruFocus
Trump Administration Engages Pharmacies, GoodRx For TrumpRx LaunchGoodRx Holdings (NASDAQ:GDRX) - Benzinga
BofA on GoodRx Holdings Inc. (GDRX): 'We don’t have a strong view at this time on the potential upside/downside from TrumpRx' - StreetInsider
GoodRx (GDRX) Shares Surge as Talks with White House Progress - GuruFocus
GoodRx: Game-Changer Partnerships on the Horizon? - StocksToTrade
GoodRx stock surges as company discusses TrumpRx role with administration - Investing.com Nigeria
GoodRx in Talks With White House on Joining TrumpRx, Reuters Reports - MarketScreener
GoodRx spikes after report on plans to join TrumpRx - Seeking Alpha
Candlestick signals on GoodRx Holdings Inc. stock todayBull Run & Growth-Oriented Investment Plans - newser.com
What machine learning models say about GoodRx Holdings Inc.Portfolio Value Summary & Accurate Buy Signal Alerts - newser.com
GoodRx (NASDAQ:GDRX) Earns Hold (C-) Rating from Weiss Ratings - MarketBeat
GoodRx Holdings, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call - The Joplin Globe
News - FinancialContent
GoodRx (GDRX) Faces Industry Changes Amid BlinkRx Developments - GuruFocus
Q2 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - The Globe and Mail
GoodRx (GDRX) Cuts Cost of Repatha to Boost Patient Savings - GuruFocus
GoodRx expands affordable access to Repatha® with nearly 60% savings - MarketScreener
$239 cash price for Repatha — GoodRx expands access with nearly 60% savings at 70,000+ pharmacies - Stock Titan
Can you recover from losses in GoodRx Holdings Inc.Portfolio Performance Report & Long-Term Capital Growth Strategies - newser.com
Is GoodRx Holdings Inc. stock entering bullish territoryShare Buyback & Safe Entry Point Alerts - newser.com
GoodRx Holdings Inc. (GDRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why GoodRx (GDRX) Stock Is Up Today - The Globe and Mail
GoodRx (GDRX): Evaluating the Stock’s Valuation After Recent Share Price Volatility - Yahoo Finance
How to recover losses in GoodRx Holdings Inc. stockWeekly Stock Summary & Entry Point Confirmation Signals - newser.com
What’s the recovery path for long term holders of GoodRx Holdings Inc.Quarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Is GoodRx Holdings Inc. stock a buy for dividend growthPrice Action & Weekly Market Pulse Alerts - newser.com
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.10%
3.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):